about
Targeting drugs to the brain by redox chemical delivery systems.A combined oral contraceptive containing 30 mcg ethinyl estradiol and 3.0 mg drospirenone does not impair endothelium-dependent vasodilation.Endothelial function, endothelin-1, and fibrinogen in young women using the vaginal contraceptive ring.Ethinyl estradiol-to-desogestrel ratio impacts endothelial function in young womenDrug targeting by retrometabolic design: soft drugs and chemical delivery systems.Oral contraceptives and lipids.Use of cyproterone acetate/ethinylestradiol in polycystic ovary syndrome: rationale and practical aspects.The role of triphasic levonorgestrel in oral contraception: a review of metabolic and hemostatic effects.Efficacy and acceptability of two monophasic oral contraceptives containing ethinylestradiol and either desogestrel or gestodene.Clinical experience and acceptability of the etonogestrel subdermal contraceptive implant.Oral contraceptives, insulin resistance and ischemic vascular disease.A long-term study of the efficacy and acceptability of a single-rod hormonal contraceptive implant (Implanon) in healthy women in China.A 4-year pilot study on the efficacy and safety of Implanon, a single-rod hormonal contraceptive implant, in healthy women in Thailand.
P2860
Q33996838-A079E284-1589-4117-B0D3-B2E98E0D899AQ34145361-9FE5AC43-2819-4282-9FC0-6A9F2F8F22F7Q34447839-26CD7FDC-BA29-4114-B358-01137D37D96EQ34447854-D869ED68-50C5-4096-BD42-A9C5CCA987C8Q34470807-7BA2CC6D-54DE-4362-B6B0-490CFD256A71Q35711674-A7339649-1795-4F83-9F11-D1458C4139D7Q39277927-1B3982DF-8B2F-46E1-ACE6-E48C99306CA8Q41156000-34FBA7CD-BFBA-401D-B05C-1A0921EF9C8BQ42688153-1D7E79B5-60F9-4A58-9C22-4A90FAAE4E90Q46618199-AFC423BF-9556-4CE9-8802-58ADCCFC0C57Q51616859-A82365DA-4157-4B81-9B41-19983FB968BDQ53927804-BB2B0BD9-2816-442C-A52D-A458A731D62CQ53947538-03B7A3F2-FBF6-450B-8CE4-E4C327838A5A
P2860
description
1985 nî lūn-bûn
@nan
1985年の論文
@ja
1985年論文
@yue
1985年論文
@zh-hant
1985年論文
@zh-hk
1985年論文
@zh-mo
1985年論文
@zh-tw
1985年论文
@wuu
1985年论文
@zh
1985年论文
@zh-cn
name
Oral contraceptives, lipids and cardiovascular disease.
@en
Oral contraceptives, lipids and cardiovascular disease.
@nl
type
label
Oral contraceptives, lipids and cardiovascular disease.
@en
Oral contraceptives, lipids and cardiovascular disease.
@nl
prefLabel
Oral contraceptives, lipids and cardiovascular disease.
@en
Oral contraceptives, lipids and cardiovascular disease.
@nl
P1433
P1476
Oral contraceptives, lipids and cardiovascular disease.
@en
P2093
Fotherby K
P304
P356
10.1016/0010-7824(85)90005-8
P577
1985-04-01T00:00:00Z